UK markets closed

Mesoblast Limited (MEOBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.76000.0000 (0.00%)
At close: 01:52PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
-
7,501
10,211
7,434
31,614
Operating expenses
Research development
-
27,189
32,815
53,012
56,188
Selling general and administrative
-
53,107
57,967
63,586
50,918
Total operating expenses
-
76,790
90,785
115,037
107,028
Operating income or loss
-
-69,289
-80,574
-107,603
-75,414
Interest expense
-
19,444
16,906
10,714
14,716
Total other income/expenses net
-
5,801
5,891
18,687
2,233
Income before tax
-
-82,101
-91,586
-99,630
-87,355
Income tax expense
-
-212
-239
-819
-9,415
Income from continuing operations
-
-81,889
-91,347
-98,811
-77,940
Net income
-
-81,889
-91,347
-98,811
-77,940
Net income available to common shareholders
-
-81,889
-91,347
-98,811
-77,940
Basic EPS
-
-0.11
-0.13
-0.15
-0.14
Diluted EPS
-
-0.11
-0.13
-0.15
-0.14
Basic average shares
858,159
779,456
684,386
638,180
557,682
Diluted average shares
858,159
779,456
684,386
638,180
557,682